EverSource Wealth Advisors
IRD icon

EverSource Wealth Advisors’s Opus Genetics IRD Stock Holding History

EverSource Wealth Advisors’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$34 Buy
+7
New +$29 ﹤0.01% 4476

Other funds holding IRD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Texas Capital Bank Wealth Management Services
Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

EverSource Wealth Advisors's IRD Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in Opus Genetics (IRD) in Q3 2026: 7 shares worth $34. The stake represents ﹤0.01% of the portfolio and ranks #4476 among its holdings.

41 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • EverSource Wealth Advisors held 7 shares of Opus Genetics worth $34 as of Q3 2026.
  • Opus Genetics was a new EverSource Wealth Advisors position in Q3 2026.
  • Opus Genetics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4476 holding.
  • 41 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.